Pfizer, Merck COVID-19 Pills US Launch In This Month; Other Countries Will Have to Wait: WSJBenzinga • 12/07/21
Merck Announces Additional $150M Investment Through 2025 to Help End Maternal Mortality InequitiesBusiness Wire • 12/07/21
Merck Announces Pause in Enrollment for Two Phase 3 Clinical Trials of Investigational, Once-Monthly, Oral Islatravir for Pre-Exposure Prophylaxis (PrEP) of HIV-1 infectionBusiness Wire • 12/06/21
Merck's Keytruda Wins Eighth FDA Approval Of 2021, This Time For Adjuvant, Pediatric Melanoma SettingsBenzinga • 12/06/21
FDA Approves Merck's KEYTRUDA® (pembrolizumab) as Adjuvant Treatment for Adult and Pediatric (≥12 Years of Age) Patients With Stage IIB or IIC Melanoma Following Complete ResectionBusiness Wire • 12/03/21
Merck to supply Government of Canada with up to 1 million courses molnupiravir, its COVID-19 pillMarket Watch • 12/03/21